What are the different types of glucose monitors available for diabetes management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Types of Glucose Monitors for Diabetes Management

There are four main types of glucose monitoring devices available for diabetes management: capillary blood glucose meters, continuous glucose monitoring (CGM) systems, intermittently scanned CGM systems, and laboratory-based monitoring methods such as HbA1c and glycated albumin. Each offers distinct advantages and limitations that should be considered when selecting the most appropriate monitoring approach.

1. Capillary Blood Glucose Monitoring (SMBG)

Capillary blood glucose monitoring, also known as self-monitoring of blood glucose (SMBG), is the most basic and widely used method:

  • Technology: Uses glucose oxidase or glucose dehydrogenase enzyme reactions to measure glucose in capillary blood samples 1
  • Usage: Requires finger pricking to obtain blood samples
  • Clinical Applications:
    • Basic form of glucose monitoring
    • Timing and frequency can be individualized based on patient's condition and treatment plan 1
    • Essential for patients on multiple daily insulin injections
    • Useful for assessing hypoglycemia, glucose levels during illness, or when discrepancies exist between A1C and glucose levels 1

Limitations:

  • Accuracy depends on both the glucose meter and user technique
  • Finger pricking causes discomfort
  • Provides only point-in-time measurements rather than continuous data
  • Interfering substances may affect readings (particularly with glucose oxidase systems) 1

2. Real-Time Continuous Glucose Monitoring (rtCGM)

  • Technology: Measures interstitial glucose through a subcutaneous sensor that correlates with plasma glucose levels

  • Features:

    • Continuously reports glucose levels (typically measuring every minute)
    • Includes alarms for both hyperglycemic and hypoglycemic excursions
    • Some systems (like Dexcom G5 and G6) are FDA-approved for treatment decisions without confirmatory blood glucose checks 1
    • Sensors typically last 7-14 days
  • Clinical Applications:

    • Strongly recommended for:
      • Adults with diabetes on multiple daily injections or insulin pumps (Grade A recommendation) 1
      • Adults with diabetes on basal insulin (Grade A/B recommendation) 1
      • Children and adolescents with type 1 diabetes (Grade B recommendation) 1
      • Patients with hypoglycemia unawareness or frequent hypoglycemic episodes 1
  • Benefits:

    • Lowers A1C levels without increasing hypoglycemia risk
    • Provides comprehensive data including time in range, time above/below range, and glycemic variability
    • Detects patterns of hyperglycemia and hypoglycemia not easily recognized by traditional monitoring 1

3. Intermittently Scanned CGM (isCGM)

  • Technology: Similar to rtCGM but requires active scanning by the user to display glucose values

  • Features:

    • Factory calibrated (no finger pricks needed for calibration)
    • Sensors typically last 14 days
    • Lower cost than rtCGM systems 2
    • Newer versions may include optional alarms
  • Clinical Applications:

    • Recommended for adults with diabetes on multiple daily injections or insulin pumps (Grade B recommendation) 1
    • Recommended for adults with diabetes on basal insulin (Grade B recommendation) 1
    • Should be scanned at least once every 8 hours for optimal benefit 1
  • Example: FreeStyle Libre system, which provides glucose readings when scanned with a reader or compatible smartphone 2

4. Laboratory-Based Monitoring Methods

HbA1c Testing

  • Reflects average glucose levels over the previous 2-3 months
  • Important for treatment adjustment and assessment of complication risks
  • Recommended testing frequency: every 3 months before achieving target, every 6 months after target is achieved 1
  • Limitation: Does not provide information on hypoglycemia or glycemic fluctuations

Glycated Albumin (GA)

  • Reflects glucose levels over the previous 2-3 weeks
  • Useful for assessment of short-term glucose control
  • May help identify stress-induced hyperglycemia 1
  • Limitation: Limited evidence base compared to other methods

Selection Criteria for Glucose Monitoring Method

The choice of glucose monitoring method should be based on:

  1. Diabetes type and treatment regimen:

    • For type 1 diabetes: rtCGM or isCGM is strongly recommended 1
    • For type 2 diabetes on multiple daily injections: rtCGM or isCGM recommended 1
    • For type 2 diabetes on basal insulin: rtCGM or isCGM recommended 1
    • For type 2 diabetes on oral medications only: routine SMBG may have limited benefit unless part of a structured program 1
  2. Risk of hypoglycemia:

    • Patients with hypoglycemia unawareness or frequent hypoglycemia should use rtCGM 1
  3. Patient capabilities and preferences:

    • Consider patient's ability to use devices safely (either independently or with caregiver assistance)
    • Patient comfort with technology
    • Cost considerations and insurance coverage

Important Considerations and Pitfalls

  • Accuracy issues: Glucose meter readings can be affected by:

    • Oxygen levels (for glucose oxidase monitors)
    • Temperature extremes
    • Interfering substances like uric acid, galactose, acetaminophen (for glucose oxidase monitors) or icodextrin (for glucose dehydrogenase monitors) 1
  • Training requirements: Proper education and training are essential for optimal implementation of any glucose monitoring system, particularly CGM 1

  • Frequency of use: CGM devices should be used as close to daily as possible for maximum benefit; isCGM devices should be scanned at least once every 8 hours 1

  • Skin reactions: Skin irritation or allergic reactions to sensor adhesives should be assessed and addressed 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Prescribing the FreeStyle Libre 3 Sensor

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.